PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
53.51%
Net income growth above 1.5x TSM's 20.37%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
37.00%
D&A growth well above TSM's 9.25%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
716.37%
Well above TSM's 31.63% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
495026.74%
SBC growth of 495026.74% while TSM is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
-132.48%
Negative yoy working capital usage while TSM is 733.20%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
266.15%
Inventory growth of 266.15% while TSM is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
No Data
No Data available this quarter, please select a different quarter.
-150.01%
Negative yoy usage while TSM is 733.20%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
100.35%
Some yoy increase while TSM is negative at -233.82%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-20.37%
Negative yoy CFO while TSM is 23.72%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-162.95%
Negative yoy CapEx while TSM is 14.48%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-3043200.00%
Negative yoy acquisition while TSM stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-108.63%
Both yoy lines negative, with TSM at -12.14%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
53.13%
At 50-75% of TSM's 94.76%. Martin Whitman questions partial disadvantage if competitor monetizes investments more efficiently.
No Data
No Data available this quarter, please select a different quarter.
-10342.61%
We reduce yoy invests while TSM stands at 60.39%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
27.55%
We slightly raise equity while TSM is negative at -516.84%. John Neff sees competitor possibly preserving share count or buying back shares.
No Data
No Data available this quarter, please select a different quarter.